arGEN-X Aktie
611,80
EUR
+11,20
EUR
+1,86
%
608,60
EUR
+4,60
EUR
+0,76
%
Werbung
arGEN-X Aktie Analyse
| 10:01 | arGEN-X Overweight | Barclays Capital | |
| 05.03.26 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 27.02.26 | arGEN-X Overweight | Barclays Capital | |
| 27.02.26 | arGEN-X Buy | Goldman Sachs Group Inc. | |
| 27.02.26 | arGEN-X Hold | Deutsche Bank AG | |
| 26.02.26 | arGEN-X Buy | Goldman Sachs Group Inc. | |
| 26.02.26 | arGEN-X Overweight | Barclays Capital | |
| 26.02.26 | arGEN-X Outperform | Bernstein Research | |
|
Werbung
|
|||
| 13.01.26 | arGEN-X Hold | Deutsche Bank AG | |
| 13.01.26 | arGEN-X Neutral | UBS AG | |
| 13.01.26 | arGEN-X Buy | Jefferies & Company Inc. | |
| 12.01.26 | arGEN-X Kaufen | DZ BANK | |
| 16.12.25 | arGEN-X Outperform | Bernstein Research | |
| 15.12.25 | arGEN-X Buy | Jefferies & Company Inc. | |
| 15.12.25 | arGEN-X Buy | Goldman Sachs Group Inc. | |
| 15.12.25 | arGEN-X Neutral | UBS AG | |
| 15.12.25 | arGEN-X Overweight | JP Morgan Chase & Co. | |
Werbung
Werbung